Latest advice on vaccine for under-fives

·1-min read


* The Australian Technical Advisory Group on Immunisation has recommended the Moderna COVID-19 vaccination for children aged six months to five years who have certain health conditions.

* The conditions cover those who are severely immunocompromised, those with a disability, and those who have complex and/or multiple health conditions which increase the risk of severe COVID-19.

* The recommendation is for two primary doses, except for those who are immunocompromised who require three primary doses, with doses eight weeks apart.

* The rollout will begin on September 5, but bookings have not yet opened.

* ATAGI does not currently recommend vaccination for children aged six months to five years who are not in the risk categories for severe COVID-19, as they have a "very low likelihood of severe illness" from COVID-19.

* The age group is one of the least likely to require hospitalisation due to COVID-19, but among the small number who are hospitalised or who die due to COVID-19, frequently present are those who have underlying medical conditions or who are immunocompromised.

* A clinical trial which included 5500 young children showed the two-dose Moderna vaccine provided modest protection against infection with an efficacy of 35 to 52 per cent.

* Most side effects were mild to moderate and lasted one to two days.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting